Preliminary Studies of the Impact of CXCL12 on the Foreign Body Reaction to Pancreatic Islets Microencapsulated in Alginate in Nonhuman Primates: Erratum

In the article by Sremac et al, “Preliminary Studies of the Impact of CXCL12 on the Foreign Body Reaction to Pancreatic Islets Microencapsulated in Alginate in Nonhuman Primates” published April 15, 2019, Dr. Mark C. Poznansky, MD, PhD, should have been listed as the senior author. The correct order of authors appears below. The author byline has been corrected in the published version. The publisher regrets this error.

Marinko Sremac, PhD,¹ Ji Lei, MD,² Madeline F.E. Penson, BS,¹ Christian Schuetz, MD,² Jonathan R.T. Lakey, PhD,³ Klearchos K. Papas, PhD,⁴ Pushkar S. Varde, PhD,⁵ Bernhard Hering, MD,⁶ Paul de Vos, PhD,⁷ Timothy Brauns, MBA,¹ James Markmann, MD, PhD,² and Mark C. Poznansky, MD, PhD¹

¹ Department of Infectious Diseases, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA.

² Division of Transplant Surgery, The Pancreas/Islet Transplant Program, Massachusetts General Hospital, Boston, MA.

³ Clinical Islet Program, Surgery School of Medicine, University of California Irvine, Irvine, CA.

⁴ Department of Surgery, Institute for Cellular Transplantation, University of Arizona, Tucson, AZ.

⁵ ViCapsys, Inc., Athens, GA.

⁶ Department of Surgery, University of Minnesota, Minneapolis, MN.

⁷ Department of Pathology and Medical Biology, University of Groningen, Groningen, The Netherlands.